The Latest
-
Retrieved from NASA's Moderate Resolution Imaging Spectroradiometer.
Manufacturers brace for price increases from Strait of Hormuz closure
Crude oil prices have surged 47% this month and polypropylene jumped 24%, affecting transportation and plastics costs.
-
Medtronic lowers earnings forecast after MiniMed IPO
The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.
-
Thermo Fisher completes $8.9B buyout of Clario
Thermo Fisher plans to create a fast-growing business by integrating Clario’s data capture and management system with its existing capabilities.
-
Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication
The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate the natural electrical system.
-
GE HealthCare wins FDA nod for photon-counting CT technology
The 510(k) decision clears the company to challenge Siemens Healthineers for an emerging part of the CT imaging sector.
-
SS Innovations ramps up in telesurgery; XCath robot treats stroke remotely
SS Innovations’ robot won approvals to perform telesurgery in Indonesia and the Philippines, while the first remote robotic mechanical thrombectomy to treat stroke was performed with XCath’s system.
-
Medtronic to distribute Merit Medical’s low back pain treatment
Merit’s basivertebral nerve ablation system is expected to round out Medtronic’s pain treatment options.
-
Labcorp closes purchase of New York pathology reference lab assets
The deal, which will see Labcorp run 12 patient service centers, is part of the company’s ongoing efforts to expand through acquisitions.
-
FTC creates healthcare task force
The task force will share resources and coordinate enforcement across the Federal Trade Commission’s disparate bureaus to better address consumer protection and competition issues in healthcare, the FTC commissioner said.
-
Medtech M&A starts off strong in 2026
Abbott closed its $21 billion purchase of Exact Sciences in March, concluding one of the largest medtech deals in recent years.
Updated March 23, 2026 -
Abbott to close $21B Exact Sciences acquisition Monday
Abbott said it has received all regulatory clearances necessary to buy the cancer screening firm.
-
CISA urges organizations to harden endpoint security following Stryker attack
The agency is coordinating with the FBI and other agencies amid concerns about additional threat activity involving Microsoft Intune.